Cancer Care

 

 

Alexey V. Danilov, MD, PhD

Contact Us
  • Keene, NH
    Phone: (603) 354-5400
  • Lebanon, NH (DHMC)
    Phone: (603) 650-5529
    Fax: (603) 650-5830
  • Manchester, NH
    Phone: (603) 629-1828
  • Nashua, NH
    Phone: (603) 577-4170
  • St. Johnsbury, VT
    Phone: (802) 473-4100
  • Cancer Help Line
    Toll-Free
    Phone: (800) 639-6918

View Dr. Danilov's Profile

Humphries LA, Godbersen JC, Danilova OV, Kaur P, Christensen B, and Danilov AV. 2013. Pro-apoptotic p53 homolog TAp63 is repressed via epigenetic silencing  and B-cell receptor signaling in chronic lymphocytic leukemia. British Journal of Haematology. doi:10.1111/bjh.12580.

Danilov AV. 2013. Targeted therapy in chronic lymphocytic leukemia: past, present and future. Clinical Therapeutics. 35(9): 1258-1270.

Danilov AV, Soderquist R, Bates D and Eastman A. 2013. Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts. Expert Review in Anticancer Therapy. 13(9): 1009-1012.

Soderquist R, Pletnev AA, Danilov AV and Eastman A. 2013. The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA. Apoptosis. doi: 10.1007/s10495-013-0910-y.

Bates D, Danilov AV, Lowrey CH and Eastman A. 2013. Vinblastine rapidly induces Noxa and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737. Molecular Cancer Therapeutics. 12(8):1504-1514.

Soderquist R, Bates D, Danilov AV and Eastman A. 2013. Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo. Leukemia. doi: 10.1038/leu.2013.138.

Holderness BM, Malhotra S, Levy NB, and Danilov AV. 2013. Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia. Journal of Clinical Oncology. 31(12): e197-199.

Danilova OV, Dumont LJ, Levy NB, Lansigan F, Kinlaw WB and Danilov AV and Kaur P.  2013. FASN and CD36 predict survival in rituximab treated diffuse large B-cell lymphoma. Journal of Hematopathology. 6 (1): 11-18.

Danilov AV, Neupane DN, Nagaraja AS, Feofanova EV, Humphries LA, Direnzo J and Korc M. 2011. DNp63a promotes oncogenesis in pancreatic cancer via trans-activation of epidermal growth factor receptor. PLoS One. 6(10):e26815.

Danilov AV, Danilova OV, Brown J, Rabinowitz A, Klein AK and Huber BT. 2010. Dipeptidyl Peptidase-2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. Experimental Hematology. 38 (12): 1167-1177.

Danilov AV, Brodsky RA, Craigo S, Smith H, Miller KB. 2010. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Leukemia Research. 34 (5): 566-571.

Danilov AV, Relias V, Feeney DM, Miller KB. 2009. Decitabine is an effective treatment of idiopathic myelofibrosis. British Journal of Haematology. 145(1): 131-132.

Danilov AV, Danilova OV, Klein AK, Huber BT. 2006. Molecular pathogenesis of chronic lymphocytic leukemia. Current Molecular Medicine. 6: 665-675.

Danilov AV, Klein AK, Lee HJ, Velez Baez D, Huber BT.  2005. Differential control of G0 program in chronic lymphocytic leukemia: a novel prognostic factor. British Journal of Haematology. 128: 472-481.